BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 18584562)

  • 1. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M; Higaki S; Shimomura Y
    Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral valaciclovir on herpetic keratitis.
    Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
    Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antiviral medications on herpetic epithelial keratitis in mice.
    Komoto S; Higaki S; Fukuda M; Shimomura Y
    Jpn J Ophthalmol; 2015 May; 59(3):194-200. PubMed ID: 25707352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acyclovir on thermal stress-induced herpesvirus reactivation.
    Gebhardt BM; Kaufman HE; Hill JM
    Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
    Higaki S; Watanabe K; Itahashi M; Shimomura Y
    Curr Eye Res; 2009 Mar; 34(3):171-6. PubMed ID: 19274523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.
    Sasaki S; Miyazaki D; Haruki T; Yamamoto Y; Kandori M; Yakura K; Suzuki H; Inoue Y
    Br J Ophthalmol; 2013 Apr; 97(4):498-503. PubMed ID: 23361434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-5021: a new acyclovir analogue inhibits murine herpetic keratitis.
    Itahashi M; Higaki S; Sugahara D; Sugioka K; Deai T; Takao K; Hayashi K; Shimomura Y
    Cornea; 2008 Apr; 27(3):334-8. PubMed ID: 18362663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Battle with herpes for 37 years].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis.
    Goldblum D; Bachmann C; Tappeiner C; Garweg J; Frueh BE
    Br J Ophthalmol; 2008 Sep; 92(9):1201-5. PubMed ID: 18650215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis.
    Remeijer L; Maertzdorf J; Buitenwerf J; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):358-63. PubMed ID: 11818377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric herpes simplex virus keratitis.
    Hsiao CH; Yeung L; Yeh LK; Kao LY; Tan HY; Wang NK; Lin KK; Ma DH
    Cornea; 2009 Apr; 28(3):249-53. PubMed ID: 19387223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
    Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of herpetic epithelial keratitis after triamcinolone acetonide subtenon injection.
    Hashizume K; Nabeshima T; Fujiwara T; Machida S; Kurosaka D
    Cornea; 2009 May; 28(4):463-4. PubMed ID: 19411969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B.
    Blatt AN; Laycock KA; Brady RH; Traynor P; Krogstad DJ; Pepose JS
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3459-65. PubMed ID: 8225880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Archipelago keratitis: a clinical variant of recurrent herpetic keratitis?
    Gabison EE; Alfonsi N; Doan S; Racine L; Sultan G; Baudouin C; Hoang-Xuan T
    Ophthalmology; 2007 Nov; 114(11):2000-5. PubMed ID: 17418418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
    Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus genome quantification in two patients who developed herpetic epithelial keratitis during treatment with antiglaucoma medications.
    Deai T; Fukuda M; Hibino T; Higaki S; Hayashi K; Shimomura Y
    Cornea; 2004 Mar; 23(2):125-8. PubMed ID: 15075880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
    Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.